ONOFRJ, Marco
 Distribuzione geografica
Continente #
NA - Nord America 18.335
EU - Europa 13.955
AS - Asia 11.789
SA - Sud America 1.948
AF - Africa 194
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 36
Totale 46.295
Nazione #
US - Stati Uniti d'America 17.994
SG - Singapore 4.856
CN - Cina 3.744
IT - Italia 2.948
IE - Irlanda 2.218
UA - Ucraina 2.106
BR - Brasile 1.618
GB - Regno Unito 1.461
TR - Turchia 1.424
SE - Svezia 1.349
DE - Germania 1.234
FR - Francia 950
FI - Finlandia 582
IN - India 564
VN - Vietnam 542
RU - Federazione Russa 423
CA - Canada 204
AR - Argentina 125
HK - Hong Kong 123
MX - Messico 110
ZA - Sudafrica 104
AT - Austria 102
NL - Olanda 98
PL - Polonia 95
JP - Giappone 88
BD - Bangladesh 83
ES - Italia 82
CZ - Repubblica Ceca 66
BE - Belgio 61
EC - Ecuador 56
KR - Corea 47
ID - Indonesia 42
IQ - Iraq 38
CO - Colombia 35
IR - Iran 34
PK - Pakistan 34
EU - Europa 31
MA - Marocco 31
VE - Venezuela 30
LT - Lituania 28
CH - Svizzera 27
LU - Lussemburgo 27
CL - Cile 26
AU - Australia 22
UZ - Uzbekistan 22
IL - Israele 21
AE - Emirati Arabi Uniti 20
PY - Paraguay 19
EG - Egitto 18
RO - Romania 17
SA - Arabia Saudita 17
NZ - Nuova Zelanda 14
PE - Perù 14
PT - Portogallo 12
TN - Tunisia 12
JO - Giordania 11
UY - Uruguay 11
KE - Kenya 10
AZ - Azerbaigian 9
NP - Nepal 9
BG - Bulgaria 8
GR - Grecia 8
NO - Norvegia 8
BO - Bolivia 7
DK - Danimarca 7
KZ - Kazakistan 7
OM - Oman 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
JM - Giamaica 6
KG - Kirghizistan 6
TW - Taiwan 6
AL - Albania 5
MY - Malesia 5
RS - Serbia 5
DZ - Algeria 4
ET - Etiopia 4
GY - Guiana 4
HR - Croazia 4
LV - Lettonia 4
PA - Panama 4
PH - Filippine 4
AM - Armenia 3
GH - Ghana 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
SR - Suriname 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BH - Bahrain 2
CY - Cipro 2
GE - Georgia 2
HN - Honduras 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
NG - Nigeria 2
PS - Palestinian Territory 2
Totale 46.266
Città #
Singapore 3.564
Chandler 2.662
Jacksonville 2.442
Dublin 2.184
Ashburn 1.070
Princeton 1.060
Dallas 992
Southend 965
Beijing 951
Izmir 751
Nanjing 682
Wilmington 516
Los Angeles 505
Munich 421
Santa Clara 419
The Dalles 414
Dearborn 412
Cambridge 377
Altamura 373
New York 331
Chieti 318
Ann Arbor 312
Tongling 284
Buffalo 263
Nanchang 241
Boardman 219
Woodbridge 194
Ho Chi Minh City 184
São Paulo 176
Rome 152
Redondo Beach 151
Houston 136
Pescara 135
Shenyang 128
Hebei 123
Helsinki 123
Milan 119
Hong Kong 115
Tianjin 111
Council Bluffs 97
Washington 95
Jiaxing 92
Kunming 91
Turku 90
Hefei 89
Hanoi 87
Grevenbroich 86
Montreal 84
Brooklyn 82
London 79
Norwalk 77
Warsaw 76
Falls Church 74
Tokyo 66
Hangzhou 63
Changsha 62
Denver 62
Nuremberg 60
Seattle 57
Chennai 56
Johannesburg 56
Vienna 56
Jinan 55
Toronto 55
Brussels 53
Dong Ket 52
Chicago 51
Rio de Janeiro 50
Atlanta 49
Stockholm 49
Phoenix 47
Brno 45
Frankfurt am Main 43
Manchester 43
Orem 43
Lanzhou 42
Belo Horizonte 40
Seoul 40
Poplar 39
Mexico City 38
Amsterdam 34
Boston 34
Ningbo 32
Mumbai 31
Florence 30
Leawood 30
Taizhou 30
Guangzhou 29
Haiphong 29
Brasília 28
Castignano 28
Changchun 28
San Francisco 28
Naples 26
Orange 26
Pune 26
San Mateo 26
Ardabil 25
Charlotte 25
Zhengzhou 25
Totale 27.716
Nome #
Emergenza neurologica - tempesta distonica: diagnosi e terapia 465
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 327
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 325
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 298
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 265
REGIONE ABRUZZO. POTENZIAMENTO DELLA DIAGNOSI PRECOCE DEL DISTURBO NEUROCOGNITIVO MINORE TRAMITE IMPLEMENTAZIONE DI UN MINIMUM DATASET E DI TECNICHE DI INTELLIGENZA ARTIFICIALE 187
Pre-trattamento antiematico per Test/terapia all'apomorfina 180
null 177
Ambiguity resolution in relative clauses: An ERPs study. 175
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 160
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 156
Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis 155
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 154
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 153
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 150
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis 148
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 146
"CADASIL coma" in an Italian homozygous CADASIL patient: comparison with clinical and MRI findings in age-matched heterozygous patients with the same G528C NOTCH3 mutation 146
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 143
Ambiguity resolution and working memory span effects: An ERPs study 142
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 142
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 141
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 141
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 140
Specializzazione funzionale della corteccia visiva nell'uomo. Studio con risonanza magnetica funzionale e potenziali evocati visivi 139
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 139
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 137
Noun animacy and ERP components modulation 136
Akinetic crisis in Dementia with Lewy Bodies 136
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 135
Progetto atrofia multisistemica: risultati preliminari. 134
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 133
Fisiopatologia dei ritardi di conduzione nella sclerosi multipla 132
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 132
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 131
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 131
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 130
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 130
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 128
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 128
BRAIN-STEM ACOUSTIC EVOKED-POTENTIALS (BAEPS) IN NEUROSURGICAL DISEASES 127
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 125
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 125
A combined EEG MEG fMRI study of the cortical activaties following pattern reversal visual stimuli 124
Bipallidal lesions induce delayed and progressive parkinsonism 124
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 124
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 123
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 123
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 123
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 123
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 122
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 121
Cerebral mapping in patients with multifocal diffractive intraocular lens 120
Asymptomatic carotid acute dissection following focal status epilepticus. 120
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 119
Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder: A Pilot Study 119
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 119
Improving diagnostic accuracy of DLB: An MRI study 119
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 119
Neuromagnetic responses reveal the cortical timing of audiovisual synchrony 118
Attention network in AD and DLB patients: a resting fMRI study. 118
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 117
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 117
Holmes-Like Tremor in Ataxia With Oculomotor Apraxia Type 2 117
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 116
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 116
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 115
Data of safety in a single-center alemtuzumab treated population 115
Stormy onset of benign childhood epilepsy with occipital paroxysmal discharges 114
Tolcapone vs entacapone: efficacia ed effetti collaterali nel trattamento della sindrome di Parkinson 114
Amantadine for dyskinesia in patients affected by severe Parkinson's disease. 114
Autoscopic phenomena: case report and review of literature. 114
Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence 114
Acute akinesia or akinetic crisis in Parkinson's disease. 113
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 113
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 113
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 113
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 113
L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain 112
Instabilità posturale nel Parkinson non farmaco-responder 112
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 112
Fronto-Parietal network subserving behaviour: the contributions of Supplementary Motor and Dorso-lateral Prefrontal Cortex in fluid reasoning. 111
Hemispheric lateralization in top-down attention during spatial relation processing: a Granger causal model approach 111
Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report 110
Echo long time STIR sequence magnetic resonance imaging of optic nerves in optic neuritis 110
Olanzapina: il nuovo trattamento della Sindrome di Gilles de La Tourette 110
Heat shock protein 70: implication for Alzheimer's disease 110
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 109
TRATTAMENTO CON TOSSINA BOTULINICA DELLA DISTONIA ASSIALE LATERALE NEL PARKINSONISMO. 108
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 108
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 108
A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum 108
Neurite ottica: relazione tra perimetria, PEV e RMN 107
A subtle mimicker in emergency department: Illustrated case reports of acute drug-induced dystonia 107
Home-based palliative approach for people with severe multiple sclerosis and their carers: Study protocol for a randomized controlled trial 107
Mitochondrial Involvement in Neurodegenerative Dementia 107
P3 topography in brain lesions 106
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 106
Pathological Gambling in PD is reduced by Amantadine 106
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 106
Totale 13.641
Categoria #
all - tutte 203.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.681 0 0 0 0 0 595 76 73 199 374 194 170
2021/20222.267 65 44 52 234 133 82 79 221 219 80 315 743
2022/20237.654 636 980 490 811 716 1.449 457 537 930 105 212 331
2023/20243.724 241 153 268 166 220 1.067 801 181 65 117 67 378
2024/20259.094 508 1.566 1.324 242 256 359 389 541 807 543 998 1.561
2025/20268.928 1.634 711 1.969 2.560 1.791 263 0 0 0 0 0 0
Totale 47.844